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Background. Excessive autophagy is amajormechanism ofmyocardial ischemia reperfusion injury (I/RI) in diabetes with enhanced
oxidative stress. Antioxidant N-acetylcysteine (NAC) reduces myocardial I/RI. It is unknown if inhibition of autophagy may
represent a mechanism whereby NAC confers cardioprotection in diabetes.Methods and Results. Diabetes was induced in Sprague-
Dawley rats with streptozotocin and they were treated without or with NAC (1.5 g/kg/day) for four weeks before being subjected to
30-minute coronary occlusion and 2-hour reperfusion.The results showed that cardiac levels of 15-F2t-Isoprostane were increased
and that autophagy was evidenced as increases in ratio of LC3 II/I and protein P62 and AMPK and mTOR expressions were
significantly increased in diabetic compared to nondiabetic rats, concomitant with increased postischemic myocardial infarct
size and CK-MB release but decreased Akt and eNOS activation. Diabetes was also associated with increased postischemic
apoptotic cell death manifested as increases in TUNEL positive cells, cleaved-caspase-3, and ratio of Bax/Bcl-2 protein expression.
NAC significantly attenuated I/RI-induced increases in oxidative stress and cardiac apoptosis, prevented postischemic autophagy
formation in diabetes, and reduced postischemic myocardial infarction (all 𝑝 < 0.05). Conclusions. NAC confers cardioprotection
against diabetic heart I/RI primarily through inhibiting excessive autophagy which might be a major mechanism why diabetic
hearts are less tolerant to I/RI.
1. Introduction
Ischemic heart disease is the most serious complication of
diabetes, which increasesmorbidity andmortality [1]. Restor-
ing of blood flow to the ischemic heart, namely, reperfusion,
is the only resolution to salvage the ischemic myocardium.
However, reperfusion itself also causes additional damage
to ischemic heart, which was termed ischemic reperfusion
injury (I/RI). Numerous studies have demonstrated that
ischemia and reperfusion induced burst production of reac-
tive oxygen species (ROS) and the consequent oxidative
damage and inflammation [2] are major mechanisms of
I/RI. Increased ROS also contribute to reduced bioavail-
ability of the cardiovascular protective nitric oxide and the
impairments of the prosurvival reperfusion injury salvage
kinase (RISK) pathway which involves PI3K/Akt and the sur-
vival activating factor enhancement (SAFE) pathway which
involves Jak/signal transducer and activator of transcription
3 (STAT3) [3].The impairment of these prosurvival pathways
may lead to the impairment of the molecular identity of
the mitochondrial permeability transition pore (mPTP) that
is decisive for cardiomyocyte survival [4], which involves
the regulation of cell apoptosis and autophagy via the
AMPK/mTOR signaling [5]. Hyperglycemia is the major
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character of diabetes, which causes ROS overproduction
and interferes with oxidant and antioxidant hemostasis and
exacerbates myocardial I/RI in diabetes. The antioxidant N-
acetylcysteine (NAC) has been shown to reduce cardiac ROS
overproduction in diabetes [6] and reduce myocardial I/RI
and improve postischemic heart function in diabetic rats
[7, 8] through attenuating I/RI-mediated apoptotic cell death.
Recent studies show that autophagy is one of the major
forms of cell death in circumstances of myocardial I/RI,
and autophagy is enhanced in the myocardium of diabetic
subjects at certain stages of the disease, when the diabetic
hearts are more vulnerable to ischemic insult. It is unknown
whether or not attenuation of autophagy may represent a
mechanism whereby NAC confers cardioprotection against
I/RI in diabetes.
Autophagy, which destructs long-lived or aggregated
proteins and damaged organelles, is a basic function of vital
life to main nutrient homeostasis, energy salvage, and degra-
dation of old, malfunctioning organelles within a cell [9]. In
addition, autophagy could provide immune protection and
invade pathogens. Recent studies show that autophagy may
have correlation with type II programmed cell death and can
initiate cell death in different circumstances and plays differ-
ent roles in neurodegenerative diseases [10], cancer [11], liver
diseases [12], cardiac diseases [13], metabolic syndromes [14],
ageing [15], and inflammations [16]. Previous study demon-
strated that autophagy was upregulated during myocardial
ischemia/reperfusion (I/R) and suggested that it may be car-
dioprotective during ischemia, but continuous activation of
autophagy during reperfusion was detrimental [17]. Adeno-
sine 5󸀠-monophosphate-activated protein kinase (AMPK) is a
sensor of energymoleculeATP and is activatedwhen the ratio
of ATP/ADP is decreased during exercise, hypoxia, oxidative
stress, glucose deprivation, and myocardial I/R [18]. AMPK
is also a major regulator/activator of autophagy [19]. On the
other hand,mammalian target of rapamycin (mTOR) inhibits
autophagy in the heart as reported. Activation of AMPK
results in decreased mTOR activity, increased autophagy,
and attenuated postischemic myocardial reperfusion injury
[20, 21]. Likewise, Guo et al. reported that ischemia post-
conditioning reduced postischemic cardiac injury through
clearing autophagosome and restoring autophagy flow [22].
However, in the diabetic myocardium, the extent of cardiac
autophagy has been shown to be either enhanced or reduced
depending onmodel and duration of the disease in which the
susceptibility to ischemic insult was enhanced [23, 24]. Thus,
the role of autophagy in diabetic myocardial I/RI is unclear.
Wehypothesize that attenuation of I/RI-induced autophagy is
a major mechanism by which NAC confers cardioprotection
in diabetes. Therefore, this study was designed to mainly
investigate the cardioprotection of NAC in diabetic rats in
relation to autophagy.
2. Materials and Methods
2.1. Induction of Diabetes. Diabetes was induced by single
dose (65mg/kg) streptozotocin (STZ) (Sigma-Aldrich, St.
Louis, MO) in male Sprague-Dawley rats (250 g, 6–8 weeks)
injection via tail vein as we described [25]. All rats were
housed in the Laboratory Animal Service Center (University
of Hong Kong) and received standard care in accordance
with the principles of Animal Care of the University of
Hong Kong. The experimental protocols were approved by
the Committee on the Use of Live Animals in Teaching and
Research (CULATR).
2.2. Experimental Protocol. Rats were randomly divided into
four groups: Ctrl: nondiabetic control; D4w: 4-week diabetes;
D4w + I/R: 4 weeks’ diabetic rats with ischemia/reperfusion;
D4w + I/R + NAC: 4 weeks’ diabetic rats treated with N-
acetylcysteine (NAC) and were subjected to ischemia/reper-
fusion (Sigma-Aldrich, St. Louis, MO). The chemicals were
dissolved in drinkingwater for 4weeks’ duration of treatment
starting one week after induction of diabetes. We selected
a dose of NAC at 1.5 g/kg/day, as our previous study has
reported that NAC at the dose of 1.4–1.5 g/kg/day completely
prevented hyperglycemia-induced oxidative stress after 8
weeks of STZ-induced diabetic rats [26].
I/R was achieved by occluding the left anterior descend-
ing (LAD) artery for 30 minutes followed by 2-hour reper-
fusion and myocardial infarction was determined using
TTC (1%, 2,3,5-triphenyltetrazolium chloride) staining as
described [27]. Briefly, at the end of reperfusion, the LAD
was reoccluded; 5% Evans Blue was injected through the
right jugular vein to mark the normal region of the left
ventricle (LV). At the completion of the experiments, the
rats were euthanized with overdose pentobarbital injection,
and the hearts were quickly removed and cut into five 1–
1.5mm cross-sectional slices and incubated in 1% TTC in
PBS at room temperature for 20 minutes. The slices were
then fixed with 10% formalin overnight. TTC stained area
was targeted as the region of survival area. Parts of the LV
tissues were selected for Western Blot. PowerLab monitoring
system (ML750 PowerLab/4sp with MLT0380 Reusable BP
Transducer; AD Instruments, CO Springs, CO) was used to
monitor the hemodynamics during myocardial I/R process.
2.3. Plasm and Cardiac Levels of Free 15-F2t-Isoprostane (15-
F2t-IsoP). Free 15-F2t-IsoP, a specific marker of oxidative
stress in vivo originally produced by the random oxidation
of tissue phospholipids, was measured by using an enzyme
immunoassay kit (Cayman chemical, Ann Arbor, MI) as
described [28]. The absorbance from the enzymatic reaction
was detected at 412 nm. The values of plasma or cardiac
free 15-F2t-IsoP were expressed as pg/mL in the plasma.
After 2 hours of reperfusion blood samples were collected
from carotid artery with anticoagulation heparin and then
centrifuged to separate plasma as we described [27].
2.4. Plasma Biochemical Analysis. Plasma tumor necrosis
factor-𝛼 (TNF-𝛼) level was determined using rat TNF-𝛼
ELISA kit (eBiosource International, Burlington, Ontario,
Canada). Plasma creatinine kinase-MB (CK-MB) levels were
determined using a commercially available rat ELISA kit
(R&D Systems, Minneapolis, MN). Plasma interleukin-6
(IL-6) level was determined using a rat IL-6 ELISA kit
(eBiosource International, Burlington,Ontario, Canada).The
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Table 1: General characteristics after STZ injection at termination of study.
Parameters C D4w D4w + NAC
Water intake (mL/kg/day) 126.3 ± 3.2 801.2 ± 12.9∗ 398.7 ± 8.3∗#
Food consumption(g/kg/day) 70.1 ± 3.8 182.7 ± 14.1∗ 129.8 ± 12.7∗#
Body weight (g) 492.5 ± 14.7 326 ± 7.9∗ 301 ± 11.7∗
Plasma glucose (Mm) 6.1 ± 0.2 27.9 ± 1.2∗ 26.8 ± 1.3∗
All values are expressed as mean ± SEM. 𝑛 = 6 per group, water intake and food consumption values were the average value of 4 weeks. Body weight, plasma
glucose, and heart/Body weight ratio were measured at 4 weeks after STZ injection. ∗𝑝 < 0.05 versus control #𝑝 < 0.05 versus D4w.
assays were performed following the manufacturer’s instruc-
tions.
2.5. In Situ Apoptotic Cell Death Detection. Apoptotic cell
death detection was achieved using TdT-mediated DUTP-
X nick end labeling (TUNEL stain) according to the manu-
facturer’s instruction (Roche Applied Science, Indianapolis,
IN, USA). First, left ventricular tissue embedded by paraffin
was sliced (5mm thick sections) and deparaffinized. Sec-
ond, the sections were permeabilized using proteinase K
(30mg/mL, 30minutes, 37∘C) and were washed in phosphate
buffered saline (PBS).Then as themanufacturer’s instructions
described to detect the apoptosis cells, DNase I was used to
induce DNA strand breaks as positive control and TdT was
omitted from the reaction mixture as negative control.
2.6. Western Blot Analysis. Proteins from frozen LV tissues
were homogenized in 1x lysis buffer fromCell Signaling Tech-
nology (Beverly, MA) and centrifuged at speed of 13200 𝑔 for
30minutes.The supernatant was collected as totalmyocardial
protein. The supernatant was collected as total myocardial
protein. The concentrations of protein were then determined
using the Bradford protein assay.
Equal protein amounts from rat heart homogenate
were resolved by 7.5–12.5% SDS-PAGE and subsequently
transferred to polyvinylidene nitrocellulose membranes and
processed as previously described [28]. Primary antibodies
against AMPK𝛼, phosphorylation AMPK𝛼, Akt, phospho-
rylation Akt (Ser-473), LC3, P62, mTOR, phosphorylation
PTEN, Bax, Bcl-2, caspase 3, cleaved-caspase-3, and GAPDH
were purchased from Cell Signaling Technology (Beverly,
MA). Protein bands were detected by a standard ECLmethod
and images were measured by a densitometer.
2.7. Statistical Analysis. All values are expressed as means
± standard error of the mean (SEM). One-way analysis of
variance (ANOVA) was used for statistical analyses (Graph-
Pad Prism, USA) of data obtained within the same group
and between groups, respectively, followed by Tukey’s test
for multiple comparisons of group means. 𝑝 values less
than 0.05 were considered to indicate statistically significant
differences.
3. Results
3.1. The Effects of NAC on General Characters, Postischemic
Myocardial Infract Size (IS), and Heart Function in Diabetic
Rats. First, we observed the effect of NAC on general
characters in diabetic rats. As shown in Table 1, in STZ-
induced diabetic rats, plasma glucose, water intake, and
food consumption were significantly increased compared to
nondiabetic rats (all 𝑝 < 0.05). After NAC treatment, food
consumption and water intake were significantly reduced
compared to diabetic group (all 𝑝 < 0.05), but NAC had
no significant effect on plasma glucose in diabetic rats (𝑝 >
0.05). Body weight in diabetic rats was significantly reduced,
and NAC had no significant impact on the body weight.
As shown in Figure 1(a), NAC significantly reduced the
postischemic myocardial infarct size (IS) in diabetic rats
(𝑝 < 0.01, NAC + D4w + I/R versus D4w + I/R). And
postischemic plasma CK-MB level after 2 hours’ reperfusion
was significantly higher compared to sham operated diabetic
group (𝑝 < 0.05 D4w + I/R versus D4W). NAC significantly
reduced postischemic CK-MB release, in accordance with
lower IS (𝑝 < 0.05).
As shown in Table 2, baseline hemodynamics dates were
similar among groups. Heart rate (HR) at baseline was not
different among the 4 groups. Coronary artery occlusion
(ischemia) reduced mean arterial pressure (MAP) and rate-
pressure product (RPP) in all groups in comparison with
baseline MAP. No significant differences in HR or RPP were
observed between groups during ischemia and reperfusion.
NAC treatment facilitated recovery of MAP after reperfusion
as compared to the diabetic untreated group.
3.2. Effects of NAC onPlasma 15-F2t-Isoprostane (15-F2t-IsoP),
Interleukin-6 (IL-6), and Tumor Necrosis Factor-𝛼 (TNF-𝛼)
Levels. We determined plasma 15-F2t-IsoP (specific marker
of oxidative stress), IL-6, and TNF-𝛼 levels in control and
diabetic rats with or without NAC treatment. As shown
in Figures 2(a), 2(b), and 2(c), plasma IL-6 and TNF-𝛼
levels were increased in the rats with diabetes along with
significant increase of 15-2t-IsoP (all 𝑝 < 0.05 D4w versus
nondiabetic group), and these were all further exacerbated
by myocardial I/RI (𝑝 < 0.05, D4w + I/R versus D4w).
NAC treatment significantly reduced but did not prevent the
increase of plasma IL-6 level in diabetic rats. By contrast,
NAC significantly decreased plasma TNF-𝛼 and 15-F2t-IsoP
level compared to diabetic rats subjected to I/R (all 𝑝 < 0.05).
3.3. Effects of NAC on Postischemic Myocardial Apoptosis,
Bax/Bcl-2, and Caspase-3 Expression. As Figure 3(a) showed,
STZ-induced diabetic rats had a significant larger number
of TUNEL-staining positive cells compared to nondiabetic
group (𝑝 < 0.05) with concomitant increases in the ratio of
Bax/Bcl-2 and cleaved-caspase-3, and myocardial I/R further
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Figure 1:The effects of NAC on heart function and infract size (IS) in diabetic rats. (a) Infarct size (IS) is expressed as a percentage of the area
at risk (AAR). (b) CK-MB release. Ischemia reperfusion (I/R) was achieved by 30-minute ischemia followed by 2-hour reperfusion in diabetic
rats with or without NAC. Ctrl: nondiabetic control; D4w: 4-week diabetes; D4w + I/R: 4-week diabetic rats with ischemia/reperfusion; D4w
+ I/R + NAC: 4-week diabetic rats treated with N-acetylcysteine (NAC) and were subjected to ischemia/reperfusion. Dates are expressed as
mean ± SEM (𝑛 = 6 per group). 𝑝 < 0.05 versus D group before ischemia; ∗𝑝 < 0.05, ∗∗𝑝 < 0.01, and ns: 𝑝 > 0.05 (no statistical significance).
Table 2: Hemodynamics at baseline, at 2 hours of reperfusion in nondiabetic or diabetic rats with or without NAC treatment.
C D D + I/R D + NAC + I/R
Baseline
HR (bpm) 268 ± 9 300 ± 9 298 ± 10 315 ± 13
MAP (mmHg) 118 ± 5 110 ± 5 113 ± 4 114 ± 3
RPP (mmHg min-1/1000) 33 ± 3 32 ± 4 34 ± 3 33 ± 3
2-hour reperfusion
HR (bpm) — — 275 ± 6 300 ± 6
MAP (mmHg) — — 70 ± 4∗ 75 ± 4∗#
RPP (mmHg min-1/1000) — — 22 ± 2∗ 24 ± 3∗
HR: heart rate; MAP: mean arterial pressure; RPP: rate-pressure product. HR, MAP, and RPP were measured at 2 hours of reperfusion. All values are expressed
as mean ± SEM (𝑛 = 6 per group). ∗𝑝 < 0.05 versus their corresponding baseline; #𝑝 < 0.05 versus D + I/R.
increased the number of apoptotic cells, whileNAC treatment
significantly attenuated the apoptotic cells induced by I/R
(𝑝 < 0.05). NAC significantly attenuated the increase in the
ratio of Bax/Bcl-2 and prevented diabetes and I/RI-induced
increase in cleaved-caspase-3 expression (all 𝑝 < 0.05).
3.4. Effects of NAC onDiabetes InducedMyocardial Autophagy
and Its Related Proteins. Autophagy has been shown to play
major roles in I/RI. As Figures 4(a) and 4(b) showed, total
and phosphorylated AMPK𝛼 (p-AMPK𝛼), a strong initiator
of autophagy, were significantly increased in themyocardium
of diabetic rats compared to that in the nondiabetic rats
(𝑝 < 0.05). I/R further increased p-AMPK𝛼 (𝑝 < 0.05)
but did not have significant effect on AMPK𝛼. The ratio of
LC3 II/I represents the extent of autophagy. As Figures 4(c)
and 4(d) showed, STZ-induced diabetic rats had significant
higher ratio of LC3 II/I compared to nondiabetic group (𝑝 <
0.05). P62, which functions to clear the autophagosome in
order to keep hemostasis, was also increased significantly
in the myocardium of diabetic rats (𝑝 < 0.05, D4w versus
nondiabetic ones). I/R did not further significantly increase
LC3 II/I and P62. NAC treatment completely prevented
diabetes induced increases of LC3 II/I and p62 proteins
expression both before and after I/R as compared to D4w +
IR (𝑝 < 0.05). In diabetic group, myocardial mTOR protein
expression significantly increased (Figure 4(e)) in parallel
with the significant increase in p-AMPK𝛼. However, during
I/R, myocardial mTORmoderately and significantly reduced
in response to I/R induced further increase in p-AMPK𝛼 (all
𝑝 < 0.05, D4w + I/R versus D4w). NAC treatment prevented
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Figure 2: Effects of NAC on plasma 15-F2t-IsoP, IL-6, and TNF-𝛼 releasing. (a) Plasma level of IL-6, (b) plasma level of TNF-𝛼, and (c)
plasma level of 15-F2t-IsoP. Ischemia reperfusion (I/R) was achieved by 30-minute ischemia followed by 2-hour reperfusion in diabetic rats
with or without NAC. Ctrl: nondiabetic control; D4w: 4-week diabetes; D4w + I/R: 4-week diabetic rats with ischemia/reperfusion; D4w +
I/R + NAC: 4-week diabetic rats treated with N-acetylcysteine (NAC) and were subjected to ischemia/reperfusion. Dates are expressed as
mean ± SEM (𝑛 = 6 per group), ∗𝑝 < 0.05 ∗∗𝑝 < 0.01.
diabetes and I/R induced increases in mTOR (𝑝 < 0.05, D4w
+ I/R + NAC versus D4w + I/R).
3.5. Changes of PTEN, Akt, and eNOS after NAC Treatment.
PTEN has been shown to play important roles in myocardial
I/R; suppression of PTEN could reduce I/RI manifested as
reduced infract size, increased Akt and eNOS activation, and
improved heart function [29, 30]. In accordance with the
previous studies, cardiac phosphorylated PTEN (p-PTEN)
protein expression (Figure 5(a)) was increased significantly
by hyperglycemia (𝑝 < 0.05, D4w versus nondiabetic rats),
and I/R further increased p-PTEN expression in diabetes.
Compared to nondiabetic group, cardiac phosphorylated Akt
(p-Akt) and eNOS (Figures 5(b) and 5(c)) were significantly
reduced in diabetic group that was concomitant with signifi-
cant increase in cardiac p-PTEN. NAC treatment completely
prevented diabetes and I/R induced increases of p-PTEN and
significantly attenuated the reduction of p-Akt and p-eNOS
induced by I/R (all 𝑝 < 0.05, D4w + I/R + NAC versus D4w
+ I/R).
4. Discussion
Hyperglycemia was the major character of diabetes along
with enhanced oxidative stress. In the current study, 15-F2t-
IsoP level was significantly increased in 4 weeks’ diabetic rats,
and NAC treatment reduced the 15-F2t-IsoP level along with
attenuating I/RI. These findings are in line with findings of
recent studies by us and other groups showing that antiox-
idant treatment with NAC can attenuate myocardial I/RI
in diabetes. The novel finding of the current study is that
autophagy is increased in the myocardium of 4 weeks’ dia-
betic rats which may be the major mechanism that rendered
the diabetic heart more vulnerable to ischemic insult and
that NAC treatment attenuates myocardial I/RI in diabetes
primarily via inhibiting and preventing excessive autophagy.
In the heart, autophagy plays critical roles in many
cardiovascular diseases in response to pathological stimuli,
including cardiac hypertrophy, heart failure, and myocardial
I/R. Autophagy is indicated to be promoted as a response
to the ATP depletion and to the ROS accumulation [31, 32].
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Figure 3: Effects of NAC on apoptosis. (a)Myocardial cell apoptosis assessed by TUNEL, (b) ratio of Bax/Bcl-2, and (c) expression of cleaved-
caspase-3. Ischemia reperfusion (I/R) was achieved by 30-minute ischemia followed by 2-hour reperfusion in diabetic rats with or without
NAC. Ctrl: nondiabetic control; D4w: 4-week diabetes; D4w + I/R: 4 weeks’ diabetic rats with ischemia/reperfusion; D4w + I/R + NAC: 4
weeks’ diabetic rats treated with N-acetylcysteine (NAC) and were subjected to ischemia/reperfusion. Dates are expressed as mean ± SEM
(𝑛 = 6 per group), ∗𝑝 < 0.05.
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Figure 4: Effects of NAC on autophagy pathway. (a) Protein AMPK expression; (b) p-AMPK; (c) ratio of LC3 II/I; (d) protein P62 expression;
(e) proteinmTOR expression. Ischemia reperfusion (I/R) was achieved by 30-minute ischemia followed by 2-hour reperfusion in diabetic rats
with or without NAC. Ctrl: nondiabetic control; D4w: 4-week diabetes; D4w + I/R: 4 weeks’ diabetic rats with ischemia/reperfusion; D4w +
I/R + NAC: 4 weeks’ diabetic rats treated with N-acetylcysteine (NAC) and were subjected to ischemia/reperfusion. Dates are expressed as
mean ± SEM (𝑛 = 6 per group), ∗𝑝 < 0.05, and ∗∗𝑝 < 0.01.
In diabetic mice, with autophagy-associated-gene (ATG5)
knockout, autophagy was impaired, leading to mitochondria
dysfunction and ROS overproduction [33], suggesting that
maintaining normal function of autophagy is critical for
diabetic heart functioning. In our previous study, we found
antioxidant NAC treatment could reduce ROS level and
I/RI in diabetic rats [8], and in the current study we found
that NAC could prevent diabetes and I/R induced excessive
autophagy and restore the normal autophagy function in
diabetic rats subjected to I/R and subsequently reducing
I/RI. The extent of cardiac autophagy has been reported
to be either reduced at [34] or enhanced [35] in diabetes
during different stages of the disease, but the impact of
autophagy on diabetic heart vulnerability to ischemic insult
is largely unknown. While moderate increase of autophagy
during myocardial ischemia has been shown to be beneficial,
excessive autophagy during reperfusion is harmful [24].
Mitochondria serve as the power of a cell, especially in cardiac
myocytes which have a large energy requirement of energy.
Mitochondrial permeability transition pore (mPTP) plays a
key role in myocardial I/RI. The increase of ROS during I/RI
enhances the likelihood of mPTP opening upon reperfusion
[4]. In this study, excessive autophagy was found in 4 weeks’
diabetic rats with myocardial I/R, which was accompanied
with high levels of 15-F2t-IsoP, IL-6, TNF-𝛼, and apoptosis,
and NAC treatment for 4 weeks attenuated all these changes,
which should have reduced mPTP opening, although further
study is needed to confirm it. And, the potential causal
relationship between diabetes induced excessive autophagy,
apoptosis, inflammation, and oxidative stress in the context
of myocardial I/RI has yet to be determined.
Autophagy is not only associated with cell survival but
has also tight relationship with cell death. As reported,
autophagic cell death is caspase independent and is clearly
distinct from apoptotic cell death but they can occur inmixed
forms with autophagic and caspase related apoptotic features.
Our results showed that NAC could reduce I/R induced cell
apoptosis, manifested by reducing positive apoptosis cells,
the ratio of Bax/Bcl-2, and expression of cleaved-caspase-
3 but has more profound effect on autophagy because it
could attenuate autophagy to a greater extent. This suggests
that, compared to apoptosis, autophagy played major roles
in diabetic I/RI, and reducing excessive autophagy may be a
potential therapy for I/RI in diabetes.
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Figure 5: Changes of PTEN, Akt, and eNOS after NAC treatment. (a) Protein p-PTEN expression; (b) protein p-Akt expression; (c) protein
p-eNOS expression. Ischemia reperfusion (I/R) was achieved by 30-minute ischemia followed by 2-hour reperfusion in diabetic rats with or
without NAC. Ctrl: nondiabetic control; D4w: 4-week diabetes; D4w + I/R: 4 weeks’ diabetic rats with ischemia/reperfusion; D4w + I/R +
NAC: 4 weeks’ diabetic rats treated with N-acetylcysteine (NAC) and were subjected to ischemia/reperfusion. Dates are expressed as mean ±
SEM (𝑛 = 6 per group), ∗𝑝 < 0.05.
AMPK is a serine-threonine kinase which functions
primarily as a metabolic sensor to coordinate anabolic and
catabolic activities in the cell to maintain the cellular energy
homeostasis via the phosphorylation of multiple proteins
involved in metabolic pathways [36]. It has effects on many
signaling pathways, such as autophagy and apoptosis [37, 38].
Our results showed that, in early diabetic rats, p-AMPK𝛼
was significantly increased which was induced by either
diabetes or diabetes with I/R and that the increase of cardiac
mTOR in diabetes was not sufficient to combat p-AMPK𝛼
to stimulate autophagy, and this led to excessive autophagy
as reflected by significant increases in the ratio of LC3 II/I
and protein P62 expression and exacerbated postischemic
I/RI. Treatment with NAC completely prevented diabetes I/R
induced increase in p-AMPK𝛼 and reduced the ratio LC3 II/I
and protein P62 expression to levels comparable to normal
control and concomitantly reduced mTOR. The fact that I/R
in diabetes did not further increase the extent of autophagy
despite I/R induced further significant increase of p-AMPK𝛼
and concomitant moderate but significant reduction in
mTOR may suggest that excessive cardiac autophagy already
occurred in diabetes is the major contributor of myocardial
I/RI. The finding that NAC could reduce the activation of
cardiac p-AMPK𝛼 is in line with our previous study [28].
In the current study, NAC restored the autophagy flow,
prevented diabetes and I/R induced increases of p-PTEN, and
attenuated the reduction of p-Akt and p-eNOS induced by I/R
to confer cardioprotection effect in diabetic rats. Inhibition
of p-PTEN has been shown to attenuate myocardial I/RI in
diabetic rats [39]. However, the potential interplay between
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PTEN and autophagy and their regulating molecules such
as mTOR in the context of diabetic myocardial I/RI has
not been reported. Findings from our current study may
serve to stimulate further in-depth studies in this interesting
and important area to foster the development of effective
therapies in combating diabetic myocardial I/RI.
In summary, we found that autophagy was excessive in 4
weeks’ diabetes and this was detrimental to I/RI. Antioxidant
treatment with NAC could suppress autophagy in 4 weeks’
diabetic rats and reduce I/RI. NAC confers cardioprotection
against diabetic heart I/RI primarily through inhibiting
excessive autophagy formation following reducing oxidant
stress in diabetes.
4.1. Clinical Perspectives. Patients with diabetes are more vul-
nerable to myocardial I/RI. The present study was designed
to investigate the role of autophagy on NAC conferring
cardioprotection effects in diabetic myocardial I/R injury.
Our results showed that autophagy was excessive in 4
weeks’ diabetes and this was detrimental to I/RI. Antioxidant
treatment with NAC could suppress autophagy in 4 weeks’
diabetic rats and reduce I/RI. It is strongly suggested that
targeting inhibition of excessive autophagymay be a potential
therapeutic strategy for the treatment of diabetes-associated
cardiac disease in patients. Patients with acute myocardial
infarction usually had increased levels of oxidative stress
that were associated with a reduction in enzymatic antiox-
idant reserve in particular in patients with diabetes, while
conditional treatments such as glucose-insulin-potassium
solution did not improve these abnormalities among patients
undergoing primary angioplasty [40]. Findings from our
current study may suggest antioxidant treatment with NAC
as a potential adjunct therapy.
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